Theravance Biopharma, Inc.: Form 8-K filed 2026-09-10
- Accepted by EDGAR
- 2026-09-10 09:10 ET
- Event date
- 2026-09-10
- Accession no.
- 0001104659-26-106567
- Original filing
- SEC EDGAR filing index
Items reported
- Item 8.01: Other Events
A voluntary disclosure of an event the company considers important to security holders that no other Item covers, such as a dividend declaration, a buyback program, litigation updates or product news.
Documents
| Type | Description | Document |
|---|---|---|
| 8-K | FORM 8-K | tm2624960d1_8k.htm |
This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.